There are more than 10 million UTI office visits a year in the US, and up to 30% of empiric antibiotic prescriptions are inappropriate. A positive PCR result tells you what's there — but not what to do about it.
Enhanced reporting closes that gap by layering resistance-marker analysis and CLSI M100 intrinsic resistance patterns onto the result, tailored to the detected pathogen. Clinicians get laboratory interpretation, not just a list of targets.
Why it matters for stewardship
When the report flags resistance markers that correlate with likely treatment failure, the clinician can avoid a drug that won't work — the essence of antibiotic stewardship. It supplements, and never replaces, established clinical protocols.
